Showing results (241-250 of 352) with videos related to

Sort By:
Pageof 36
Health Affairs (Project Hope)|July 10, 2018
Specialty Drug Coverage Varies Across Commercial Health Plans In The USJames D Chambers, David D Kim, Elle F Pope, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|May 16, 2017
The influence of time horizon on results of cost-effectiveness analysesDavid D Kim, Colby L Wilkinson, Elle F Pope, et al.
Academic Radiology|July 4, 2012
Medicare's national coverage determinations in diagnostic radiology: examining evidence and setting limitsHansel Javier Otero, James D Chambers, Brian W Bresnahan, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 18, 2017
A Review of Empirical Analyses of Disinvestment InitiativesJames D Chambers, Mark N Salem, Brittany N D'Cruz, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Public HealthPei-Jung Lin, Abigail G Riley, Patricia G Synnott, et al.
Pharmacoeconomics|June 16, 2011
A review of the costs and cost effectiveness of interventions in chronic kidney disease: implications for policyJoseph Menzin, Lisa M Lines, Daniel E Weiner, et al.
Applied Health Economics and Health Policy|November 11, 2016
Estimating Population Health Benefits Associated with Specialty and Traditional Drugs in the Year Following Product ApprovalJames D Chambers, Teja Thorat, Colby L Wilkinson, et al.
International Journal of Technology Assessment in Health Care|January 12, 2010
Are Key Principles for improved health technology assessment supported and used by health technology assessment organizations?, Peter J Neumann, Michael F Drummond, et al.
Journal of Comparative Effectiveness Research|November 19, 2013
Principles for planning and conducting comparative effectiveness researchBryan R Luce, Michael F Drummond, Robert W Dubois, et al.
Pageof 36